https://www.selleckchem.com/pr....oducts/Tigecycline.h
6 mm ± 25.6; p = 0.043) and 48% (- 33 mm ± 40.2; p = 0.08, respectively from baseline. After 2 weeks, average VAS scores remained 56% and 37% below baseline, respectively. There were no adverse events and all patients were satisfied after the procedure. Suprascapular and median nerve blocks are safe and well-tolerated procedures for acute pain control in post-stroke SHS. Further studies should address the benefit of these procedures on overall pain reduction, functional recovery, and quality of life in SHS patients. Suprascapular